表紙
市場調查報告書

過敏性咳嗽症候群 (CHS) 治療藥的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·預測 (2019∼2027年)

Cough Hypersensitivity Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 920502
出版日期 內容資訊 英文 167 Pages
商品交期: 最快1-2個工作天內
價格
過敏性咳嗽症候群 (CHS) 治療藥的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·預測 (2019∼2027年) Cough Hypersensitivity Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年11月01日內容資訊: 英文 167 Pages
簡介

本報告提供全球過敏性咳嗽症候群 (CHS) 治療藥的市場相關分析,提供市場基本結構和主要的影響要素,市場規模趨勢預測,各類藥物·各流通管道及地區別·主要國家詳細趨勢,競爭環境 (市場佔有率結構),主要企業簡介等調查。

第1章 序論

第2章 前提條件·分析方法

第3章 摘要整理:全球 市場

第4章 市場概要

  • 簡介
    •  定義
    • 產業趨勢/發展
  • 概要
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 市場分析與預測 (總計11年份)
    • 市場規模的預測 (以金額為準)
  • 波特的五力分析

第5章 主要考察

  • 過敏性咳嗽症候群 (CHS)的流行病學
  • 開發中產品分析

第6章 全球過敏性咳嗽症候群 (CHS) 治療藥市場:各類藥物

  • 簡介/定義
  • 分析概要/市場趨勢
  • 市場規模的預測:各類藥物 (以金額為準,總計11年份)
    • 止咳劑
    • 吸入皮質類固醇 (ICS)
    • 短時間作用型β2促效劑 (SABA)
    • 抗膽鹼促效劑
    • 抗組織胺藥物
    • 質子幫浦抑制劑
    • 其他
  • 市場向心力分析:各類藥物

第7章 全球CHS治療藥市場:各流通管道

  • 簡介/定義
  • 分析概要/市場趨勢
  • 市場規模的預測:各流通管道 (以金額為準,總計11年份)
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 市場向心力分析:各流通管道

第8章 全球CHS治療藥市場:各地區

  • 簡介/定義
  • 分析概要/市場趨勢
  • 市場規模的預測:各地區 (以金額為準,總計11年份)
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場向心力分析:各地區

第9章 北美的CHS治療藥市場:分析與預測

  • 簡介
  • 市場規模的預測:各類藥物 (以金額為準,總計11年份)
  • 市場規模的預測:各流通管道 (以金額為準,總計11年份)
  • 市場規模的預測:各國 (以金額為準,總計11年份)
    • 美國,加拿大
  • 市場向心力分析:各類藥物·各流通管道·各國

第10章 歐洲的CHS治療藥市場:分析與預測

  • 市場規模的預測:各國 (以金額為準,總計11年份)
    • 德國,英國,法國,西班牙,義大利等

第11章 亞太地區的CHS治療藥市場:分析與預測

  • 市場規模的預測:各國 (以金額為準,總計11年份)
    • 中國,日本,印度,澳洲·紐西蘭等

第12章 南美的CHS治療藥市場:分析與預測

  • 市場規模的預測:各國 (以金額為準,總計11年份)
    • 巴西,墨西哥等

第13章 中東·非洲的CHS治療藥市場:分析與預測

  • 市場規模的預測:各國 (以金額為準,總計11年份)
    • 波灣合作理事會 (GCC) 各國,南非等

第14章 競爭環境

  • 市場競爭矩陣 (各層級·不同企業規模)
  • 市場佔有率分析:各企業
    • Pfizer, Inc.
      • 企業概要 (總公司所在地,事業區分,員工數等)
      • 財務分析概要
      • 產品系列
      • 策略概要
      • SWOT分析
    • GlaxoSmithKline plc
    • Boehringer Ingelheim GmbH
    • AstraZeneca
    • F. Hoffmann-La Roche Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Merck & Co., Inc. (Merck Sharp & Dohme Corp)
    • Vertex Pharmaceuticals Incorporated
    • Johnson & Johnson Consumer Inc.
目錄

Cough Hypersensitivity Syndrome Treatment Market - Scope of the Report

TMR'S report on the global cough hypersensitivity syndrome treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market, for the forecast period of 2019 to 2027. The report provides the overall revenue of the global cough hypersensitivity syndrome treatment market from 2017 to 2027, with 2018 as the base year and 2017 as the historical year. The report also provides the compound annual growth rate (CAGR) for the global cough hypersensitivity syndrome treatment market for the period of 2019 to 2027.

The report has been prepared after extensive primary and secondary research. Primary research involves bulk of the research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global cough hypersensitivity syndrome treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various phenomena in the global cough hypersensitivity syndrome treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cough hypersensitivity syndrome treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global cough hypersensitivity syndrome treatment market.

The report delves into the competitive landscape of the global cough hypersensitivity syndrome treatment market. Key players operating in the global cough hypersensitivity syndrome treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global cough hypersensitivity syndrome treatment market that have been profiled in this report.

Key Questions Answered in the Cough Hypersensitivity Syndrome Treatment Market Report

What is the revenue expected to be generated by cough hypersensitivity syndrome treatment for each drug class across all regions during the forecast period?

What are the opportunities in the global cough hypersensitivity syndrome treatment market?

What are the major drivers, restraints, opportunities, and threats in the global cough hypersensitivity syndrome treatment market?

Which regional market is likely to expand at the maximum CAGR during the forecast period?

Which cough hypersensitivity syndrome treatment distribution channel is expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?

What is the position of different companies operating in the global cough hypersensitivity syndrome treatment market?

Cough Hypersensitivity Syndrome Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global cough hypersensitivity syndrome treatment market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides a detailed explanation of the objectives behind this study, and the pipeline analysis of different drugs in the treatment of cough hypersensitivity syndrome. This report also provides the epidemiological overview of the cough hypersensitivity syndrome, globally, and in main countries.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables, appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows the comparison of market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cough Hypersensitivity Syndrome Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Respiratory Drug Classes Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Epidemiology Cough hypersensitivity syndrome
  • 5.2. Pipeline Analysis

6. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Drug Class, 2017-2027
    • 6.3.1. Antitussive Agents
    • 6.3.2. Inhaled Corticosteroids (ICS)
    • 6.3.3. Short Acting Beta2-Agonists (SABA)
    • 6.3.4. Anti-cholinergics
    • 6.3.5. Antihistamines
    • 6.3.6. Proton Pump Inhibitors
    • 6.3.7. Others
  • 6.4. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class

7. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
  • 7.4. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Distribution Channel

8. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, By Region

  • 8.1. Key Findings
  • 8.2. Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Region

9. North America Cough Hypersensitivity Syndrome Treatment Market Value Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017-2027
    • 9.2.1. Antitussive Agents
    • 9.2.2. Inhaled Corticosteroids (ICS)
    • 9.2.3. Short Acting Beta2-Agonists (SABA)
    • 9.2.4. Anti-cholinergics
    • 9.2.5. Antihistamines
    • 9.2.6. Proton Pump Inhibitors
    • 9.2.7. Others
  • 9.3. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017-2027
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. North America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country, 2017-2027
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis
    • 9.5.1. By Drug Class
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017-2027
    • 10.2.1. Antitussive Agents
    • 10.2.2. Inhaled corticosteroids (ICS)
    • 10.2.3. Short-Acting Beta2-Agonists (SABA)
    • 10.2.4. Anti-cholinergics
    • 10.2.5. Antihistamines
    • 10.2.6. Proton Pump Inhibitors
    • 10.2.7. Others
  • 10.3. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017-2027
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017-2027
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis
    • 10.5.1. By Drug Class
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country

11. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017-2027
    • 11.2.1. Antitussive Agents
    • 11.2.2. Inhaled corticosteroids (ICS)
    • 11.2.3. Short-Acting Beta2-Agonists (SABA)
    • 11.2.4. Anti-cholinergics
    • 11.2.5. Antihistamines
    • 11.2.6. Proton Pump Inhibitors
    • 11.2.7. Others
  • 11.3. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017-2027
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017-2027
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis
    • 11.5.1. By Drug Class
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017-2027
    • 12.2.1. Antitussive Agents
    • 12.2.2. Inhaled corticosteroids (ICS)
    • 12.2.3. Short-Acting Beta2-Agonists (SABA)
    • 12.2.4. Anti-cholinergics
    • 12.2.5. Antihistamines
    • 12.2.6. Proton Pump Inhibitors
    • 12.2.7. Others
  • 12.3. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017-2027
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017-2027
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis
    • 12.5.1. By Drug Class
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Drug Class, 2017-2027
    • 13.2.1. Antitussive Agents
    • 13.2.2. Inhaled corticosteroids (ICS)
    • 13.2.3. Short-Acting Beta2-Agonists (SABA)
    • 13.2.4. Anti-cholinergics
    • 13.2.5. Antihistamines
    • 13.2.6. Proton Pump Inhibitors
    • 13.2.7. Others
  • 13.3. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Distribution Channel, 2017-2027
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast By Country/Sub-region, 2017-2027
    • 13.4.1. GCC
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis
    • 13.5.1. By Drug Class
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis by Company (2018)
  • 14.3. Company Profiles
    • 14.3.1. Pfizer, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Strategic Overview
      • 14.3.1.5. SWOT Analysis
    • 14.3.2. GlaxoSmithKline plc
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Strategic Overview
      • 14.3.2.5. SWOT Analysis
    • 14.3.3. Boehringer Ingelheim GmbH
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Strategic Overview
      • 14.3.3.5. SWOT Analysis
    • 14.3.4. AstraZeneca
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Strategic Overview
      • 14.3.4.5. SWOT Analysis
    • 14.3.5. F. Hoffmann-La Roche Ltd.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Strategic Overview
      • 14.3.5.5. SWOT Analysis
    • 14.3.6. Teva Pharmaceutical Industries Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Strategic Overview
      • 14.3.6.5. SWOT Analysis
    • 14.3.7. Novartis AG
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Strategic Overview
      • 14.3.7.5. SWOT Analysis
    • 14.3.8. Merck & Co., Inc. (Merck Sharp & Dohme Corp)
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Strategic Overview
      • 14.3.8.5. SWOT Analysis
    • 14.3.9. Vertex Pharmaceuticals Incorporated
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Strategic Overview
      • 14.3.9.5. SWOT Analysis
    • 14.3.10. Johnson & Johnson Consumer Inc.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Strategic Overview
      • 14.3.10.5. SWOT Analysis

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 03: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 04: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 05: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 06: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 07: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 08: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 09: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 10: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 11: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 12: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 13: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 14: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 15: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 16: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 17: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 18: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 19: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
  • Figure 02: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 03: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Drug Class (2019)
  • Figure 04: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Distribution Channel (2019)
  • Figure 05: Global Cough Hypersensitivity Syndrome Treatment Market Value Share (%), by Region (2019)
  • Figure 06: Porter's Five Force Analysis- Cough Hypersensitivity Syndrome Treatment Market
  • Figure 07: Epidemiology of Cough Hypersensitivity Syndrome (Chronic Cough)
  • Figure 08: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 09: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Antitussive Agents, 2017-2027
  • Figure 10: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Inhaled Corticosteroids, 2017-2027
  • Figure 11: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Short acting Beta-2 Agonists, 2017-2027
  • Figure 12: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Anticholinergics, 2017-2027
  • Figure 13: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2027
  • Figure 14: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Proton Pump Inhibitors, 2017-2027
  • Figure 15: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Others, 2017-2027
  • Figure 16: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Drug Class, 2019?2027
  • Figure 17: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 18: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Hospital Pharmacies, 2017-2027
  • Figure 19: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Retail Pharmacies, 2017-2027
  • Figure 20: Global Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, by Online Pharmacies, 2017-2027
  • Figure 21: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019?2027
  • Figure 22: Global Cough Hypersensitivity Syndrome Treatment Market: Regional Outlook
  • Figure 23: Global Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 24: Global Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 25: North America Cough Hypersensitivity Syndrome Treatment market Value (US$ Mn) Forecast, 2019-2027
  • Figure 26: North America Cough Hypersensitivity Syndrome Treatment market Value Share, by Country, 2018 and 2027
  • Figure 27: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness, by Country, 2019-2027
  • Figure 28: North America Cough Hypersensitivity Syndrome Treatment market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 29: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness Analysis, by Drug Class, 2019?2027
  • Figure 30: North America Cough Hypersensitivity Syndrome Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 31: North America Cough Hypersensitivity Syndrome Treatment market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 32: Europe Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 33: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 34: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 36: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class, 2019?2027
  • Figure 35: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 37: Europe Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 38: Europe Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 39: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 40: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 41: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 42: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 43: Asia Pacific Cough Hypersensitivity Syndrome Market Attractiveness Analysis, by Drug Class, 2019?2027
  • Figure 44: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 45: Asia Pacific Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 46: Latin America Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 47: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 48: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 49: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 50: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness Analysis, by Drug Class, 2019?2027
  • Figure 51: Latin America Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 52: Latin America Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 53: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • Figure 54: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 55: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 56: Middle East & Africa Cough Hypersensitivity Syndrome Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 57: Middle East & Africa Cough Hypersensitivity Syndrome Market Attractiveness Analysis, by Drug Class, 2019?2027
  • Figure 58: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 59: Middle East & Africa Cough Hypersensitivity Syndrome Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 60: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 61: Pfizer, Inc. Breakdown of Net Sales (%), by Region, 2018
  • Figure 62: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 63: Pfizer, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 64: GSK R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 65: GSK Breakdown of Net Sales (%), by Geography, 2018
  • Figure 66: GSK Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 67: GSK Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 68: Boehringer Ingelheim GmbH R&D Expenditure (US$ Mn), 2016-2018
  • Figure 69: Boehringer Ingelheim GmbH Breakdown of Net Sales, by Region (Company Level), 2018
  • Figure 70: Boehringer Ingelheim GmbH Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2018
  • Figure 71: Boehringer Ingelheim GmbH Breakdown of Net Sales, by Business Segment, 2018
  • Figure 72: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 73: AstraZeneca Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 74: AstraZeneca R&D Expenses (US$ Mn), 2015-2018
  • Figure 75: AstraZeneca Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 76: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015-2018
  • Figure 77: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Business Segment, 2018
  • Figure 78: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region, 2018
  • Figure 79: F. Hoffmann-La Roche Ltd. Research & Development Cost (US$ Mn), 2015-2017
  • Figure 80: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015-2018
  • Figure 81: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 82: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2015-2018
  • Figure 83: Novartis AG Breakdown of Net Sales, by Region, 2018
  • Figure 84: Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017-2018
  • Figure 85: Novartis AG Breakdown of Net Sales, by Business Segment, 2018
  • Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 87: Merck & Co., Inc. Revenue Breakdown of Net Sales (%), by Segment, 2018
  • Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 89: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 90: Vertex Pharmaceuticals Incorporated Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 91: Vertex Pharmaceuticals Incorporated Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 92: Vertex Pharmaceuticals Incorporated R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 93: Johnson & Johnson Consumer Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 94: Johnson & Johnson Consumer Inc. Breakdown of Net Sales (%), by Region, 2018
  • Figure 95: Johnson & Johnson Consumer Inc. Breakdown of Net Sales (%), by Business Segment, 2018